{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:55:18Z","timestamp":1794099318760,"version":"4.8.0"},"reference-count":27,"publisher":"Massachusetts Medical Society","issue":"3","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["089725\/B\/09\/Z"],"award-info":[{"award-number":["089725\/B\/09\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["119993"],"award-info":[{"award-number":["119993"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,1,21]]},"DOI":"10.1056\/nejmoa2028220","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T13:10:26Z","timestamp":1605273026000},"page":"216-228","source":"Crossref","is-referenced-by-count":255,"title":["Polypill with or without Aspirin in Persons without Cardiovascular Disease"],"prefix":"10.1056","volume":"384","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-5601","authenticated-orcid":false,"given":"Salim","family":"Yusuf","sequence":"first","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Joseph","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dans","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Gao","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Xavier","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"L\u00f3pez-Jaramillo","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Yusoff","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Santoso","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Gamra","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Talukder","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Christou","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Girish","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Yeates","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freeda","family":"Xavier","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dagenais","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Rocha","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"McCready","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tyrwhitt","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-4207","authenticated-orcid":false,"given":"Jackie","family":"Bosch","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Pais","sequence":"additional","affiliation":[{"name":"From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.Y., P.J., P. Gao, K.T., C.C., T.M., J.T., J.B.), Queen\u2019s University, Kingston, ON (K. Yeates), and Universit\u00e9 Laval Institut Universitaire de Cardiologie et de Pneumologie de Qu\u00e9bec, Quebec, QC (G.D.) \u2014 all in Canada; the University of the Philippines, Manila (A.D.); St. John\u2019s Medical College, Bangalore, India (D.X., P. Girish, F.X., P.P.); Fundaci\u00f3n Oftalmol\u00f3gica de Santander,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"GBD 2017 Causes of Death Collaborators","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1736-1788.30496103","journal-title":"Lancet"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.","volume":"395","author":"Dagenais GR","year":"2020","unstructured":"Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2020;395:785-794.31492501","journal-title":"Lancet"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1923-1994.30496105","journal-title":"Lancet"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.","volume":"395","author":"Yusuf S","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 2020;395:795-808.31492503","journal-title":"Lancet"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.","volume":"360","author":"The Prospective Studies Collaboration","year":"2002","unstructured":"The Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.12493255","journal-title":"Lancet"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.","volume":"364","author":"Yusuf S","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.15364185","journal-title":"Lancet"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%.","volume":"326","author":"Wald NJ","year":"2003","unstructured":"Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-1419.12829553","journal-title":"BMJ"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Collaboration","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-1860.19482214","journal-title":"Lancet"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events; a systematic review and meta-analysis.","volume":"321","author":"Zheng SL","year":"2019","unstructured":"Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events; a systematic review and meta-analysis. JAMA 2019;321:277-287.30667501","journal-title":"JAMA"},{"key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2018.07.012","article-title":"The International Polycap Study-3 (TIPS-3): design, baseline characteristics and challenges in conduct.","volume":"206","author":"Joseph P","year":"2018","unstructured":"Joseph P, Pais P, Dans AL, et al. The International Polycap Study-3 (TIPS-3): design, baseline characteristics and challenges in conduct. Am Heart J 2018;206:72-79.30342297","journal-title":"Am Heart J"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurheartj\/ehq448","article-title":"Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score.","volume":"32","author":"McGorrian C","year":"2011","unstructured":"McGorrian C, Yusuf S, Islam S, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J 2011;32:581-589.21177699","journal-title":"Eur Heart J"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/heartjnl-2017-311609","article-title":"Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.","volume":"104","author":"Joseph P","year":"2018","unstructured":"Joseph P, Yusuf S, Lee SF, et al. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart 2018;104:581-587.29066611","journal-title":"Heart"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events.","volume":"62","author":"Lin DY","year":"2000","unstructured":"Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc B 2000;62:711-730.","journal-title":"J R Stat Soc B"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/01621459.1999.10473831","article-title":"Nonparametric estimation of a recurrent survival function.","volume":"94","author":"Wang M-C","year":"1999","unstructured":"Wang M-C, Chang S-H. Nonparametric estimation of a recurrent survival function. J Am Stat Assoc 1999;94:146-153.24244058","journal-title":"J Am Stat Assoc"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.","volume":"363","author":"Heart Protection Study Collaborative Group","year":"2004","unstructured":"Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-767.15016485","journal-title":"Lancet"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.","volume":"373","author":"The Indian Polycap Study (TIPS)","year":"2009","unstructured":"The Indian Polycap Study (TIPS) Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet 2009;373:1341-1351.19339045","journal-title":"Lancet"},{"key":"e_1_3_5_18_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCOUTCOMES.111.963637","article-title":"Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (Polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators.","volume":"5","author":"Yusuf S","year":"2012","unstructured":"Yusuf S, Pais P, Sigamani A, et al. Comparison of risk factor reduction and tolerability of a full-dose polypill (with potassium) versus low-dose polypill (Polycap) in individuals at high risk of cardiovascular diseases: the Second Indian Polycap Study (TIPS-2) investigators. Circ Cardiovasc Qual Outcomes 2012;5:463-471.22787067","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.","volume":"361","author":"Sever PS","year":"2003","unstructured":"Sever PS, Dahl\u00f6f B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158.12686036","journal-title":"Lancet"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease.","volume":"374","author":"Yusuf S","year":"2016","unstructured":"Yusuf S, Bosch J, Dagenais G, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016;374:2021-2031.27040132","journal-title":"N Engl J Med"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.","volume":"326","author":"Law MR","year":"2003","unstructured":"Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427-1427.12829555","journal-title":"BMJ"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease.","volume":"374","author":"Lonn EM","year":"2016","unstructured":"Lonn EM, Bosch J, L\u00f3pez-Jaramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med 2016;374:2009-2020.27041480","journal-title":"N Engl J Med"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial.","volume":"394","author":"Roshandel G","year":"2019","unstructured":"Roshandel G, Khoshnia M, Poustchi H, et al. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet 2019;394:672-683.31448738","journal-title":"Lancet"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease.","volume":"374","author":"Yusuf S","year":"2016","unstructured":"Yusuf S, Lonn E, Pais P, et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med 2016;374:2032-2043.27039945","journal-title":"N Engl J Med"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.","volume":"384","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2014","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014;384:591-598.25131978","journal-title":"Lancet"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease.","volume":"354","author":"Lonn E","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-1577.16531613","journal-title":"N Engl J Med"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","article-title":"MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.12114037","journal-title":"Lancet"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","article-title":"A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.","volume":"394","author":"Schwalm JD","year":"2019","unstructured":"Schwalm JD, McCready T, Lopez-Jaramillo P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet 2019;394:1231-1242.31488369","journal-title":"Lancet"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2028220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:32:55Z","timestamp":1711485175000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2028220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1,21]]}},"alternative-id":["10.1056\/NEJMoa2028220"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2028220","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}